Invention Grant
- Patent Title: Treatment of hidradenitis suppurativa using JAK inhibitors
-
Application No.: US16370436Application Date: 2019-03-29
-
Publication No.: US11304949B2Publication Date: 2022-04-19
- Inventor: Michael D. Howell , Paul Smith
- Applicant: Incyte Corporation
- Applicant Address: US DE Wilmington
- Assignee: Incyte Corporation
- Current Assignee: Incyte Corporation
- Current Assignee Address: US DE Wilmington
- Agency: Fish & Richardson P.C.
- Main IPC: A61K31/397
- IPC: A61K31/397 ; C07D403/00 ; A61K31/519 ; A61K31/573 ; A61K45/06
Abstract:
The present application provides methods of treating hidradenitis suppurativa in a patient in need thereof, comprising administering to the patient a therapeutically effective amount of a compound which inhibits JAK1 and/or JAK2, or a pharmaceutically acceptable salt thereof.
Public/Granted literature
- US20190328739A1 TREATMENT OF HIDRADENITIS SUPPURATIVA USING JAK INHIBITORS Public/Granted day:2019-10-31
Information query
